Video

Novartis Contract Manufacturing Capacity Update July 2024: Large Molecule Development

This presentation from the July 2024 OPCU event showcases the Novartis Contract Manufacturing capabilities in tech transfer, clinical drug substance, and commercial drug substance manufacturing across our manufacturing network in Singapore, Europe, and the US.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Novartis Contract Manufacturing